Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin type A injections are not effective for severe alopecia areata.

Botox injections may be a safe and effective way to treat severe, itchy skin disease when other treatments fail.

Botulinum toxin type A is a safe and effective treatment for male pattern baldness.

Botulinum toxin A helped a patient recover from dissecting folliculitis when antibiotics failed.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

Botulinum toxin affects hair follicles, inhibiting TGF-B1 secretion; more research ongoing.

Repeated botulinum toxin injections for forehead wrinkles may cause hairline recession in some women.

Botulinum toxin injections may help treat hair loss by blocking harmful secretion in hair follicles.

Botulinum toxin type A reduces itch and inflammation from histamine and may help treat certain skin conditions and hair loss.

Botulinum toxin type A injections improved hair growth and scalp health in a woman with radiation-induced hair loss.

Combining botulinum toxin type A with Minoxidil significantly improves hair growth and patient satisfaction in male hair loss.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Botox can help prevent hair loss by blocking cell death in scalp cells.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Botulinum toxin may help reduce stress-related hair loss.

Botulinum toxin may help treat hair loss but needs more research for effectiveness and cost concerns.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Botulinum toxin type A and platelet-rich plasma together boost hair growth by activating specific growth pathways.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

Botulinum toxins show promise in treating various conditions, but more research is needed for hair and scalp disorders.

Botulinum toxin is used in skin care for cosmetic and medical purposes.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The document concludes that there is a need for more research and regulation in dermatology, covering topics like latex allergy in children, the use of botulinum toxin, and treatments for skin conditions.